SG Americas Securities’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

SG Americas Securities’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-100,065	Closed	-$21.7M	–	3426
2021 Q1	$21.7M	Buy	+100,065	New	+$18.8M	0.11%	159
2020 Q4	–	Sell	-1,428	Closed	-$139K	–	3542
2020 Q3	$139K	Buy	+1,428	New	+$164K	﹤0.01%	2322
2017 Q1	–	Sell	-2,556	Closed	-$286K	–	3659
2016 Q4	$286K	Buy	+2,556	New	+$308K	﹤0.01%	2073
2015 Q1	–	Sell	-1,537	Closed	-$104K	–	3205
2014 Q4	$104K	Buy	+1,537	New	+$112K	﹤0.01%	2896
2014 Q2	–	Sell	-6,900	Closed	-$410K	–	2772
2014 Q1	$410K	Buy	+6,900	New	+$410K	﹤0.01%	1589

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

SG Americas Securities's GWPH Position: Q2 2021 in Review

SG Americas Securities sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 100,065 shares — an estimated $21.7M sold.

SG Americas Securities first reported a position in GWPH in Q1 2014 and held it in 5 quarters. The position peaked at $21.7M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

SG Americas Securities reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
SG Americas Securities sold 100,065 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $21.7M.
SG Americas Securities first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and held it in 5 quarters.
SG Americas Securities's GW Pharmaceuticals Plc American Depositary Shares position peaked at $21.7M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on SG Americas Securities's 13F filing for Q2 2021, filed 12 Aug 2021.